Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: August-16-16
Credit Expiration Date: August-30-17

Faculty

Michael E. Wechsler, MD, MMSc
Director, Asthma Program
Professor of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health
Denver, CO

Monica Kraft, MD
Professor of Medicine
Chair, Department of Medicine
The Robert and Irene Flinn Endowed Chair of Medicine
University of Arizona
Tucson, AZ

Credit Hours

1.0

Medium

Mobile + Online on RealCME

Program Description

This activity is the first in a 2-part interactive series titled "Point of Care Clinical Decisions in Asthma Management." Approximately 25.7 million Americans suffer from asthma, a chronic inflammatory disorder of the airways, resulting in recurrent episodes of airflow limitation, mucus production, and cough. Despite many effective therapies and recent advances, many patients continue to experience suboptimal outcomes including activity limitation, missed school or work days, emergency department visits, hospitalizations, and death. This activity will examine optimal evidence-based diagnosis and care.

Program Developer/Facilitator


.

Target Audience

Primary care physicians, community pulmonologists, allergists and other clinicians involved in the management of patients with asthma.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Follow guideline recommendations for the diagnosis and assessment of asthma.
  2. Use spirometry and standardized questionnaires to assess disease severity.
  3. Develop guideline-recommended treatment plans for patients with asthma based on disease severity.
  4. Provide asthma patient education and tools to engage patients as active partners in their asthma care.

Disclosures

Michael E Wechsler, MD, MMSc, discloses the following relationships with commercial interests:
Consultant--Sanofi, AstraZeneca, Novartis, Teva, Genentech, Theravance, Vectura, Mylan, Regeneron, Boston Scientific, Meda, Tunitas

Monica Kraft, MD, discloses the following relationships with commercial interests:
Consultant--Teva, AstraZeneca, Genentech
Grant Funding--Roche, Sanofi, Chiesi

Rick Ricer, MD, Physician Reviewer, University of Cincinnati, has no conflicts of interest to disclose.
Susan P. Tyler, MEd, CMP, CHCP, FACEHP, University of Cincinnati, has no conflicts of interest to disclose.
Joshua Kilbridge, Medical Writer, has no conflicts of interest to disclose.
Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose.
Terry Ann Glauser, MD, MPH, Vice President, Medical Affairs, MCM Education has no conflicts of interest to disclose.

The University of Cincinnati requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

In this educational activity, the faculty reports their presentation will not contain reference to investigational and/or off-label uses.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Credit Statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release date: August 16, 2016
Last review date: August 16, 2016
Expiration date: August 30, 2017

Commercial Support Statements

This activity is supported by an educational grant from Novartis.

Certificate Fee

$0.00

Disclaimer

2016 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the University of Cincinnati, or Novartis. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS